Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Chiron news

CHIR and SynPep Corp. settled a lawsuit alleging that SynPep (Dublin, Calif.) infringed CHIR patents in combinatorial chemistry (see BioCentury Aug. 29, 1994). SynPep

Read the full 240 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE